[{"address1": "75 State Street", "address2": "Suite 100", "city": "Boston", "state": "MA", "zip": "02109", "country": "United States", "phone": "617 229 6499", "website": "https://www.finchtherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company develops FIN-211, a microbiome candidate designed to address the gastrointestinal and behavioral symptoms of autism spectrum disorder; and FIN-524 for the prevention, diagnosis, theragnosis or treatment of diseases in humans, including ulcerative colitis; FIN-525 for the treatment of Crohn's disease; and other microbiome product candidates. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; and license agreements with Skysong Innovations LLC, OpenBiome, Arizona State University, and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Boston, Massachusetts.", "fullTimeEmployees": 1, "companyOfficers": [{"maxAge": 1, "name": "Mr. Matthew P. Blischak J.D.", "age": 62, "title": "President, Secretary & CEO", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 558807, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James S. Sigler MBA", "age": 64, "title": "Executive Vice President of CMC", "yearBorn": 1961, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 14.15, "open": 14.4, "dayLow": 14.4, "dayHigh": 14.4, "regularMarketPreviousClose": 14.15, "regularMarketOpen": 14.4, "regularMarketDayLow": 14.4, "regularMarketDayHigh": 14.4, "payoutRatio": 0.0, "beta": 1.165, "forwardPE": -0.6993686, "volume": 600, "regularMarketVolume": 600, "averageVolume": 4060, "averageVolume10days": 830, "averageDailyVolume10Day": 830, "bid": 14.01, "ask": 14.99, "bidSize": 100, "askSize": 100, "marketCap": 23123000, "fiftyTwoWeekLow": 10.9, "fiftyTwoWeekHigh": 16.1, "allTimeHigh": 675.0, "allTimeLow": 0.8, "priceToSalesTrailing12Months": "Infinity", "fiftyDayAverage": 13.77536, "twoHundredDayAverage": 13.05325, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 36076988, "profitMargins": 0.0, "floatShares": 1563515, "sharesOutstanding": 1605763, "sharesShort": 19195, "sharesShortPriorMonth": 10600, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.012, "heldPercentInsiders": 0.03402, "heldPercentInstitutions": 0.0, "shortRatio": 0.19, "shortPercentOfFloat": 0.0276, "impliedSharesOutstanding": 1605764, "bookValue": 8.855, "priceToBook": 1.6262, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -14167000, "trailingEps": -8.8, "forwardEps": -20.59, "lastSplitFactor": "1:30", "lastSplitDate": 1686528000, "enterpriseToEbitda": -1.85, "52WeekChange": 0.2863636, "SandP52WeekChange": 0.14799047, "quoteType": "EQUITY", "currentPrice": 14.4, "recommendationKey": "none", "totalCash": 16035000, "totalCashPerShare": 9.986, "ebitda": -19506000, "totalDebt": 28989000, "quickRatio": 3.594, "currentRatio": 3.872, "totalRevenue": 0, "debtToEquity": 203.875, "revenuePerShare": 0.0, "returnOnAssets": -0.2189, "returnOnEquity": -0.67280996, "grossProfits": 0, "freeCashflow": -15963625, "operatingCashflow": -18055000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "FNCH", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "shortName": "Finch Therapeutics Group, Inc.", "longName": "Finch Therapeutics Group, Inc.", "regularMarketChangePercent": 1.7667845, "regularMarketPrice": 14.4, "exchange": "PNK", "messageBoardId": "finmb_320858778", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "epsTrailingTwelveMonths": -8.8, "epsForward": -20.59, "fiftyDayAverageChange": 0.6246395, "fiftyDayAverageChangePercent": 0.045344695, "twoHundredDayAverageChange": 1.3467493, "twoHundredDayAverageChangePercent": 0.10317349, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-03-19", "cryptoTradeable": false, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1616160600000, "regularMarketChange": 0.25, "regularMarketDayRange": "14.4 - 14.4", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 4060, "fiftyTwoWeekLowChange": 3.5, "fiftyTwoWeekLowChangePercent": 0.32110092, "marketState": "CLOSED", "corporateActions": [], "regularMarketTime": 1768597200, "fiftyTwoWeekRange": "10.9 - 16.1", "fiftyTwoWeekHighChange": -1.7000008, "fiftyTwoWeekHighChangePercent": -0.105590105, "fiftyTwoWeekChangePercent": 28.63636, "displayName": "Finch Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-17"}]